Skip to content

13F-HR/A filed by DSAM Partners (London) Ltd

DSAM Partners (London) Ltd filed this 13F-HR/A for the quarter ended 2020-09-30, filed 2020-11-18, with 2 holding rows worth $13,061,000.

Accession
0001172661-20-002349
Filed
2020-11-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, amendment of type new holdings, 2 entries on the cover page, a total value of $13,061,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $13,061,000 with VALUE read as thousands by filing date, 13F file number 028-15090. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Oracle Corporation68389X105COM150,000$8,955,000thousands by filing datecall
ROCKET PHARMACEUTICALS INC77313F106COM179,630$4,106,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-20-002221 superseded2020-11-16acceptance time not in the bulk data set
13F-HR/A 0001172661-20-002348 base2020-11-18acceptance time not in the bulk data set
13F-HR/A 0001172661-20-002349this filing2020-11-18acceptance time not in the bulk data set